Home/Filings/4/0001179110-17-000726
4//SEC Filing

CymaBay Therapeutics, Inc. 4

Accession 0001179110-17-000726

CIK 0001042074operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 7:33 PM ET

Size

5.9 KB

Accession

0001179110-17-000726

Insider Transaction Report

Form 4
Period: 2017-01-04
OMara Patrick J.
VP, Business Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-01-04+12,50025,000 total
    Exercise: $1.82From: 2017-01-04Exp: 2026-07-24Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]On July 25, 2016, the Reporting Person was granted an option to purchase 25,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met on December 30, 2016, resulting in vesting of the option as to 12,500 shares, which was reported on a prior Form 4. The second milestone was met on January 4, 2017, resulting in vesting of the option as to the remaining 12,500 shares.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001042074

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:33 PM ET
Size
5.9 KB